Guardian Pharmacy Services (GRDN) Expected to Announce Earnings on Tuesday

Guardian Pharmacy Services (NYSE:GRDN) is anticipated to release its earnings data before the market opens on Tuesday, February 11th. Analysts expect Guardian Pharmacy Services to post earnings of $0.20 per share for the quarter. Guardian Pharmacy Services has set its FY 2024 guidance at EPS.

Guardian Pharmacy Services (NYSE:GRDN) last posted its quarterly earnings data on Tuesday, November 12th. The company reported ($2.00) EPS for the quarter, missing analysts’ consensus estimates of $0.19 by ($2.19). The firm had revenue of $314.39 million during the quarter, compared to the consensus estimate of $303.21 million. On average, analysts expect Guardian Pharmacy Services to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Guardian Pharmacy Services Price Performance

NYSE:GRDN opened at $22.07 on Tuesday. Guardian Pharmacy Services has a twelve month low of $14.16 and a twelve month high of $25.74. The firm’s 50-day simple moving average is $22.16.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on GRDN. Raymond James assumed coverage on Guardian Pharmacy Services in a research report on Monday, October 21st. They set an “outperform” rating and a $21.00 target price on the stock. Stephens started coverage on Guardian Pharmacy Services in a report on Tuesday, October 22nd. They set an “overweight” rating and a $21.00 price objective for the company. Finally, Truist Financial increased their price target on shares of Guardian Pharmacy Services from $22.00 to $24.00 and gave the stock a “buy” rating in a research note on Friday, November 15th.

Insider Activity

In related news, Director Steven D. Cosler bought 7,000 shares of Guardian Pharmacy Services stock in a transaction that occurred on Tuesday, November 19th. The stock was acquired at an average price of $21.22 per share, for a total transaction of $148,540.00. Following the completion of the purchase, the director now owns 17,713 shares in the company, valued at approximately $375,869.86. This represents a 65.34 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.